Organogenesis Holdings (ORGO) Short-term Investments (2017 - 2026)

Organogenesis Holdings' Short-term Investments history runs 10 years deep, the most recent figure standing at $720000.0 for Q1 2026.

• On a quarterly basis, Short-term Investments rose 26.54% year-over-year to $720000.0 in Q1 2026; TTM through Mar 2026 was $720000.0, a 26.54% increase from a year earlier, with the FY2025 full-year figure at $652000.0, up 12.41% from the prior year.
• Short-term Investments improved to $720000.0 in Q1 2026 per ORGO's latest filing, from $652000.0 in the prior quarter.
• Across five years, Short-term Investments topped out at $812000.0 in Q4 2022 and bottomed at $498000.0 in Q4 2023.
• The 5-year median for Short-term Investments is $627000.0 (2025), against an average of $644117.6.
• Across the five-year window, Short-term Investments surged 58.32% in 2022 and tumbled 38.67% in 2023, its largest moves.
• Year by year, Short-term Investments stood at $812000.0 in 2022, then tumbled by 38.67% to $498000.0 in 2023, then rose by 16.47% to $580000.0 in 2024, then gained by 12.41% to $652000.0 in 2025, then rose by 10.43% to $720000.0 in 2026.
• Per Business Quant, the three latest ORGO Short-term Investments figures stand at $720000.0 (Q1 2026), $652000.0 (Q4 2025), and $627000.0 (Q3 2025).